Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diapath is a leading Italian medical technology company specializing in the field of anatomic pathology. The company designs, develops, and manufactures a comprehensive range of instruments, reagents, and consumables used in histology and cytology laboratories. Their product portfolio includes automated tissue processors, microtomes, and staining systems, such as the Donatello and Galileo series, aimed at improving diagnostic accuracy and laboratory efficiency. Diapath serves hospitals, research centers, and private laboratories globally, focusing on the critical pre-analytical and analytical phases of cancer diagnosis. The company is recognized for its commitment to innovation and high-quality manufacturing standards, maintaining a strong 'Made in Italy' identity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diapath.